Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01338857
What this trial is testing

Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas

Who this might be right for
neurofibromatosis1 (NF1)Recurrent or Progressive Optic Pathway Gliomas (OPG)Recurrent or Progressive Low-grade Glioma
NYU Langone Health 12
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Testing effectiveness (Phase 2)Ended earlyNCT01968590
What this trial is testing

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1 (NF1)
University of Utah 26
Testing effectiveness (Phase 2)Study completedNCT01553149
What this trial is testing

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

Who this might be right for
Neurofibromatosis Type 1Recurrent Childhood Pilocytic AstrocytomaRecurrent Childhood Visual Pathway Glioma
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04954001
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621082
What this trial is testing

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

Who this might be right for
Neurofibromatosis 1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 19
Large-scale testing (Phase 3)UnknownNCT00921037
What this trial is testing

First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibromas
Medical University of Vienna 12
Early research (Phase 1)Study completedNCT00727233
What this trial is testing

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type IPlexiform Neurofibroma
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00624234
What this trial is testing

Neurobiology and Treatment of Reading Disability in NF-1

Who this might be right for
Neurofibromatosis Type 1Reading Disabilities
Vanderbilt University 184
Testing effectiveness (Phase 2)Study completedNCT00030264
What this trial is testing

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 23
Testing effectiveness (Phase 2)WithdrawnNCT05825365
What this trial is testing

Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromasPost-operative
AstraZeneca
Not applicableUnknownNCT01626846
What this trial is testing

How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem

Who this might be right for
Neurofibromatosis Type 1
John Jay High School 50
Early research (Phase 1)Study completedNCT00053937
What this trial is testing

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
National Cancer Institute (NCI)
Not applicableStudy completedNCT00026780
What this trial is testing

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Who this might be right for
Ewing SarcomaOsteosarcomaNeuroblastoma+2 more
National Cancer Institute (NCI) 1,720
Not applicableStudy completedNCT06262113
What this trial is testing

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 294
Not applicableStudy completedNCT05912400
What this trial is testing

Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
University of Arkansas 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT03190915
What this trial is testing

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic LeukemiaNeurofibromatosis Type 1
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06735820
What this trial is testing

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Who this might be right for
Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma
AeRang Kim 45
Not applicableStudy completedNCT00303368
What this trial is testing

Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia

Who this might be right for
Neurofibromatosis Type 1Tibial Dysplasia
Shriners Hospitals for Children 395
Testing effectiveness (Phase 2)UnknownNCT03741101
What this trial is testing

Treatment of NF1-related Plexiform Neurofibroma With Trametinib

Who this might be right for
Neurofibromatosis 1ChildNeurofibroma, Plexiform
Region Skane 15
Next Page